Using this system, the effects of variants and mutations of RAP1, GFAPɛ, APP, and the presenilins can help show how these proteins function together in EOAD to provide insight into the mechanisms that produce Aβ peptides leading to plaque formation, a hallmark of AD pathology. This evidence concerns the gene GFAP and Alzheimer disease.